Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

被引:0
作者
Friederike Holze
Patrick Vizeli
Felix Müller
Laura Ley
Raoul Duerig
Nimmy Varghese
Anne Eckert
Stefan Borgwardt
Matthias E. Liechti
机构
[1] University Hospital Basel,Department of Biomedicine and Department of Clinical Research, Division of Clinical Pharmacology and Toxicology
[2] University of Basel,Psychiatric University Hospital (UPK)
[3] University of Basel,Transfaculty Research Platform Molecular and Cognitive Neuroscience
[4] University of Basel,undefined
来源
Neuropsychopharmacology | 2020年 / 45卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d-amphetamine is used for the treatment of attention-deficit/hyperactivity disorder. All three substances induce distinct acute subjective effects. However, differences in acute responses to these prototypical psychoactive substances have not been characterized in a controlled study. We investigated the acute autonomic, subjective, and endocrine effects of single doses of LSD (0.1 mg), MDMA (125 mg), d-amphetamine (40 mg), and placebo in a randomized, double-blind, cross-over study in 28 healthy subjects. All of the substances produced comparable increases in hemodynamic effects, body temperature, and pupil size, indicating equivalent autonomic responses at the doses used. LSD and MDMA increased heart rate more than d-amphetamine, and d-amphetamine increased blood pressure more than LSD and MDMA. LSD induced significantly higher ratings on the 5 Dimensions of Altered States of Consciousness scale and Mystical Experience Questionnaire than MDMA and d-amphetamine. LSD also produced greater subjective drug effects, ego dissolution, introversion, emotional excitation, anxiety, and inactivity than MDMA and d-amphetamine. LSD also induced greater impairments in subjective ratings of concentration, sense of time, and speed of thinking compared with MDMA and d-amphetamine. MDMA produced greater ratings of good drug effects, liking, high, and ego dissolution compared with d-amphetamine. d-Amphetamine increased ratings of activity and concentration compared with LSD. MDMA but not LSD or d-amphetamine increased plasma concentrations of oxytocin. None of the substances altered plasma concentrations of brain-derived neurotrophic factor. These results indicate clearly distinct acute effects of LSD, MDMA, and d-amphetamine and may assist the dose-finding in substance-assisted psychotherapy research.
引用
收藏
页码:462 / 471
页数:9
相关论文
共 305 条
[1]  
Krebs TS(2013)Over 30 million psychedelic users in the United States F1000 Res 2 98-27
[2]  
Johansen PO(2017)Modern clinical research on LSD Neuropsychopharmacology 42 2114-53
[3]  
Liechti ME(2015)Acute effects of lysergic acid diethylamide in healthy subjects Biol Psychiatry 78 544-57
[4]  
Schmid Y(2017)The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation Curr Biol 27 451-37
[5]  
Enzler F(2016)Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens Eur Neuropsychopharmacol 26 1327-97
[6]  
Gasser P(2017)Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression Front Pharmacol 8 974-80
[7]  
Grouzmann E(2016)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial J Psychopharmacol 30 1181-32
[8]  
Preller KH(2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial J Psychopharmacol 30 1165-45
[9]  
Vollenweider FX(2008)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later J Psychopharmacol 22 621-64
[10]  
Preller KH(2018)Long-lasting subjective effects of LSD in normal subjects Psychopharmacology 235 535-2745